Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
Imke Jenniches, Svenja Ternes, Önder Albayram, et al.
Biological Psychiatry (2015) Vol. 79, Iss. 10, pp. 858-868
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz, Giovanni Marsicano, Rafaël Maldonado, et al.
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 12, pp. 705-718
Open Access | Times Cited: 422
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 412
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel, Alexander Stumpf, Hai‐Ying Zhang, et al.
Neuron (2016) Vol. 90, Iss. 4, pp. 795-809
Open Access | Times Cited: 278
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 221
Neurobiology of fear and specific phobias
René García
Learning & Memory (2017) Vol. 24, Iss. 9, pp. 462-471
Open Access | Times Cited: 212
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 80-102
Open Access | Times Cited: 202
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 188
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition
Daisuke Ogasawara, Hui Deng, Andreu Viader, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 113, Iss. 1, pp. 26-33
Open Access | Times Cited: 141
Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Nora D. Volkow, Aidan J. Hampson, Rubén Baler
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 285-308
Open Access | Times Cited: 121
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure
Rebecca J. Bluett, Rita Báldi, Andre Haymer, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 120
Neurosteroid biosynthesis down‐regulation and changes in GABAA receptor subunit composition: a biomarker axis in stress‐induced cognitive and emotional impairment
Andrea Locci, Graziano Pinna
British Journal of Pharmacology (2017) Vol. 174, Iss. 19, pp. 3226-3241
Open Access | Times Cited: 112
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 102
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety
Gaurav Bedse, Nolan D. Hartley, Emily Neale, et al.
Biological Psychiatry (2017) Vol. 82, Iss. 7, pp. 488-499
Open Access | Times Cited: 94
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 79
Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?
Leah M. Mayo, Christine A. Rabinak, Matthew N. Hill, et al.
Biological Psychiatry (2021) Vol. 91, Iss. 3, pp. 262-272
Open Access | Times Cited: 66
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 57
Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression
Yifan Li, Xinglun Dang, Rui Chen, et al.
Nature Human Behaviour (2025)
Open Access | Times Cited: 1
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress
Clémentine Bosch‐Bouju, Thomas Larrieu, Louisa Linders, et al.
Cell Reports (2016) Vol. 16, Iss. 5, pp. 1237-1242
Open Access | Times Cited: 82
Neuroactive steroids and PTSD treatment
Ann M. Rasmusson, Brian P. Marx, Suzanne L. Pineles, et al.
Neuroscience Letters (2017) Vol. 649, pp. 156-163
Open Access | Times Cited: 80
Age-related changes in the endocannabinoid system in the mouse hippocampus
Anastasia Piyanova, Ermelinda Lomazzo, Laura Bîndilă, et al.
Mechanisms of Ageing and Development (2015) Vol. 150, pp. 55-64
Closed Access | Times Cited: 78
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling
Peggy Schneider, Laura Bîndilă, Christian Schmahl, et al.
Frontiers in Behavioral Neuroscience (2016) Vol. 10
Open Access | Times Cited: 77
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
Maria Morena, Kira D. Leitl, Haley A. Vecchiarelli, et al.
Neuropharmacology (2016) Vol. 111, pp. 59-69
Closed Access | Times Cited: 67
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans
Douglas R. Smith, Christine M. Stanley, Theodore Foss, et al.
PLoS ONE (2017) Vol. 12, Iss. 11, pp. e0187926-e0187926
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top